… often referred to as "cytokine storm." While the immunopathogenesis remains unclear,
prospects of treating this severe phase of the illness with immunotherapy are evolving, with some …

… SARS-CoV-2 mediated cytokine storm is associated with the mortality and morbidity of
COVID-19 patients. The key cytokines implicated in the onset of disease severity include TNF-α, …

… Cytokine storm syndrome (CSS) has generally been described as a collection of clinical
manifestations resulting from an overactivated immune system. Cytokine storms (CSs) are …

… This paper focuses on the mechanism of CS induced by the SARS-CoV-2 virus and its
clinical manifestations, and reviews the recently reported immunotherapies for cytokine storm, …

… immunotherapy has shown remarkable efficacy, it also suffers from limitations such as irAEs,
cytokine storm, … , and limitations of cancer immunotherapy. Besides, by combining cancer …

… and inflammatory storms, the application of immunotherapy will have a high prospect. Just as
a … subpopulation that promotes the inflammatory cytokine storms by using single-cell mRNA …

… immune system, cytokines may become harmful to the body, leading to a state of systemic
hyperinflammation called a cytokine storm [1]. Cytokine storm underlies several pathological …

… Immunoregulatory therapies target the cytokine storms induced by severe acute respiratory
… In this review, cytokine storms caused by SARS‑CoV‑2 infections are evaluated and …

… responses induced by radiation, especially the cytokine storm and the underlying mechanisms
such as DAMPs release, pro-inflammatory cytokine secretion and cGAS-STING pathway …

… Other Janus kinase (Ruxolitinib(30), TofacitinibNoclinical trials to date) as well as Bruton's
Tyrosine kinase inhibitors were used or proposed to do so to treat cytokine storm in COVID-19 …